MedPath

Intimacy and Mindfulness Post-Prostate Cancer Treatment

Not Applicable
Completed
Conditions
Sexual Dysfunction
Prostate Cancer
Registration Number
NCT03177707
Lead Sponsor
Vancouver Prostate Centre
Brief Summary

With improvements in detection and treatment of prostate cancer (PCa), more men than ever are living with side effects from PCa treatment; most distressingly, treatment side effects include problems with sexual functioning (e.g. erectile dysfunction, climacturia, inorgasmia). This study aims to develop a mindfulness-based group treatment for couples with sexual functioning complaints post-PCa treatment. Couples will be invited to a four-session mindfulness-based treatment group. Pre- and post-treatment outcomes (e.g., distress, sexual functioning/enjoyment, relationship satisfaction, treatment adherence) will assess feasibility and effectiveness of this novel treatment for couple's sexual lives after PCa.

Detailed Description

This is an intervention study designed to assess a novel mindfulness-based treatment protocol for couples dealing with sexual dysfunction secondary to prostate cancer treatment. Couples will be invited to participate through the Vancouver Prostate Centre (VPC) and the Prostate Cancer Survivorship Care (PCSC) Program. Interested couples will be screened for eligibility. Eligible couples will be randomized to either an immediate-start or a delayed-waitlist control group.

Prior to treatment, couples will complete an online questionnaire package. Treatment will consist of a 4-week mindfulness-based group lead by a clinician trained in mindfulness treatment. Sessions are 2hrs in length and take place in consecutive weeks, with daily homework recommended between sessions. The intervention was developed based on pre-existing mindfulness-based cognitive therapy treatment groups for sexual dysfunction developed by Dr. Lori Brotto at the UBC Sexual Health Laboratory, mindfulness in sex therapy and intimate relationships (MSIR) treatment group developed by Kocsis and Newbury-Helps (2016), and expert input. Sessions consist of mindfulness-based training, sex therapy techniques, and education. After treatment, couples will be invited to complete a post-treatment questionnaire once immediately after the end of treatment, and again 6 months later.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
28
Inclusion Criteria
  • Currently in a relationship that has lasted longer than 1 year
  • Both members of the couple are at least 19 years of age or older
  • Both members of the couple are able to speak and read English (to date, all of the treatment material is delivered in English)
  • (At least) one member of the couple has a history of prostate cancer diagnosis
  • The same member of the couple underwent radical prostatectomy for the treatment of his prostate cancer
  • Both members of the couple are willing and able to comply with all study procedures (including committing to daily homework over the 4-week period of the treatment program) and be available for the duration of the study
  • Both members of the couple provide signed and dated informed consent form
Exclusion Criteria
  • The individual who was treated with prostate cancer received androgen deprivation therapy or radiation therapy to treat their prostate cancer.
  • Have a current health condition (e.g., severe cardiovascular health problems, unmanaged diabetes mellitus), physical disabilities, or mental health issues (e.g., severe anxiety, depression) that would interfere with self- or partnered-sexual activities, or the individual's ability to attend group sessions or complete home assignments

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Sexual correlates: GMSEXChange from post-intervention (5 weeks) to 6-month follow up

GMSEX (Lawrance \& Byers, 1992). The GMSEX is a 5-item measure of distress related to sexual functioning with one's partner.

Sexual correlates: Self-reported sexual functioningChange from baseline to post-intervention (5 weeks)

Depending on sexual orientation and gender, individuals will complete either (1) International Index of Erectile Functioning (heterosexual men), International Index of Erectile Functioning for Men who have sex with men (gay men), or Female Sexual Functioning Index (female partners)

Sexual correlates: Self-reported erectile functioningChange from post-intervention (5 weeks) to 6-month follow up

Depending on sexual orientation and gender, individuals will complete either (1) International Index of Erectile Functioning (heterosexual men), International Index of Erectile Functioning for Men who have sex with men (gay men), or Female Sexual Functioning Index (female partners)

Sexual correlates: Sexual activity scaleChange from post-intervention (5 weeks) to 6-month follow up

This is a questionnaire developed by the study lead that asks individual to rate the frequency of times that they engaged in a range of sexual activities over 3 time-periods: (a) ever, (b) since their/their partner's prostate cancer surgery, and (c) in the past 4 weeks.

Sexual correlates: Adapted dyadic adjustment scaleChange from post-intervention (5 weeks) to 6-month follow up

Adapted dyadic adjustment scale (A-DAS; Sharpley \& Cross, 1982). The A-DAS is a validated, 7-item measure that assesses relationship adjustment.

Secondary Outcome Measures
NameTimeMethod
mental and health-related quality of life indices: Hospital Anxiety and Depression ScaleChange from post-intervention (5 weeks) to 6-month follow up

Hospital Anxiety and Depression Scale (HADS; Zigmond \& Snaith, 1983). The HADS is a validated, 14-item measure of depression and anxiety..

mental and health-related quality of life indices: UCLA Prostate Cancer IndexChange from post-intervention (5 weeks) to 6-month follow up

UCLA Prostate Cancer Index (Litwin, Hays, Fink, Ganz, Leake, \& Brook, 1998). This is a 20-item measure that assesses health-related quality of life indices specific to common side effects of prostate cancer treatment.

Trial Locations

Locations (1)

Vancouver Prostate Centre

🇨🇦

Vancouver, British Columbia, Canada

Vancouver Prostate Centre
🇨🇦Vancouver, British Columbia, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.